Benedict Daniel Michael1, Michael J Griffiths2, Julia Granerod3, David Brown4, Geoff Keir5, Małgorzata Wnęk6, Daniel J Cox7, Rishma Vidyasagar7, Ray Borrow8, Laura M Parkes7, Tom Solomon1. 1. Institute of Infection and Global Health Health Protection Research Unit in Emerging and Zoonotic Infections, National Institute for Health Research, University of Liverpool Walton Centre National Health Service (NHS) Foundation Trust. 2. Institute of Infection and Global Health Health Protection Research Unit in Emerging and Zoonotic Infections, National Institute for Health Research, University of Liverpool Alderhey Children's NHS Foundation Trust, Liverpool. 3. Public Health England, London. 4. Public Health England, London Influenza and Measles Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. 5. Walton Centre National Health Service (NHS) Foundation Trust. 6. Institute of Infection and Global Health. 7. Faculty of Medical and Human Sciences, Centre for Imaging Sciences, Institute of Population Health, University of Manchester. 8. Vaccine Evaluation Unit, Public Health England, Manchester, United Kingdom.
Abstract
BACKGROUND: Encephalitis is parenchymal brain inflammation, commonly due to herpes simplex virus (HSV). Key host inflammatory mediators and their relationship to blood-brain barrier (BBB) permeability, neuroimaging changes, and disease outcome are poorly understood. METHODS: We measured levels of 38 mediators in serum (n = 78) and cerebrospinal fluid (n = 37) specimens from patients with encephalitis, including 17 with disease due to HSV infection. Outcome measures were Glasgow coma and outcome scores; CSF to serum albumin ratio, reflecting BBB permeability; and, in patients with HSV infection, magnetic resonance imaging-based temporal lobe volume. RESULTS: Serum interleukin 1 receptor antagonist (IL-1RA) levels were elevated in patients with a good outcome (P= .004). Among patients infected with HSV, the ratio of CSF IL-1β to IL-1RA was associated with a worse outcome (P= .009); a ratio of ≥0.55 pg/mL had high specificity and sensitivity for a poor outcome (100% and 83%;P= .015). Temporal lobe volume had a negative correlation with serum IL-1RA level (P= .012) and a positive correlation with serum IL-1α level (P= .0003) and CSF IL-1β level (P= .007). A normal coma score was associated with an elevated interleukin 10 (IL-10) level in serum specimens from HSV-infected patients (P= .007) and CSF specimens from all patients (P= .016); the IL-10 level correlated inversely with BBB permeability (P= .005). CONCLUSIONS: A proinflammatory cytokine response is associated with greater clinical severity, BBB permeability, and neuroimaging damage during encephalitis. IL-1 antagonists should be investigated as adjunctive treatment in encephalitis.
BACKGROUND:Encephalitis is parenchymal brain inflammation, commonly due to herpes simplex virus (HSV). Key host inflammatory mediators and their relationship to blood-brain barrier (BBB) permeability, neuroimaging changes, and disease outcome are poorly understood. METHODS: We measured levels of 38 mediators in serum (n = 78) and cerebrospinal fluid (n = 37) specimens from patients with encephalitis, including 17 with disease due to HSV infection. Outcome measures were Glasgow coma and outcome scores; CSF to serum albumin ratio, reflecting BBB permeability; and, in patients with HSV infection, magnetic resonance imaging-based temporal lobe volume. RESULTS: Serum interleukin 1 receptor antagonist (IL-1RA) levels were elevated in patients with a good outcome (P= .004). Among patients infected with HSV, the ratio of CSFIL-1β to IL-1RA was associated with a worse outcome (P= .009); a ratio of ≥0.55 pg/mL had high specificity and sensitivity for a poor outcome (100% and 83%;P= .015). Temporal lobe volume had a negative correlation with serum IL-1RA level (P= .012) and a positive correlation with serum IL-1α level (P= .0003) and CSFIL-1β level (P= .007). A normal coma score was associated with an elevated interleukin 10 (IL-10) level in serum specimens from HSV-infectedpatients (P= .007) and CSF specimens from all patients (P= .016); the IL-10 level correlated inversely with BBB permeability (P= .005). CONCLUSIONS: A proinflammatory cytokine response is associated with greater clinical severity, BBB permeability, and neuroimaging damage during encephalitis. IL-1 antagonists should be investigated as adjunctive treatment in encephalitis.
Authors: Uta K Meyding-Lamadé; Christoph Oberlinner; Philipp R Rau; Sonja Seyfer; Sabine Heiland; Johann Sellner; Brigitte T Wildemann; Wolfram R Lamadé Journal: J Neurovirol Date: 2003-02 Impact factor: 2.643
Authors: Peter M Winter; Nguyen Minh Dung; Ha Thi Loan; Rachel Kneen; Bridget Wills; Le Thi Thu; Deborah House; Nicholas J White; Jeremy J Farrar; C Anthony Hart; Tom Solomon Journal: J Infect Dis Date: 2004-09-29 Impact factor: 5.226
Authors: Benedict D Michael; Laura Bricio-Moreno; Elizabeth W Sorensen; Yoshishige Miyabe; Jeffrey Lian; Tom Solomon; Evelyn A Kurt-Jones; Andrew D Luster Journal: Cell Rep Date: 2020-09-15 Impact factor: 9.423
Authors: Kavitha Kothur; Louise Wienholt; Shekeeb S Mohammad; Esther M Tantsis; Sekhar Pillai; Philip N Britton; Cheryl A Jones; Rajeshwar R Angiti; Elizabeth H Barnes; Timothy Schlub; Sushil Bandodkar; Fabienne Brilot; Russell C Dale Journal: PLoS One Date: 2016-08-30 Impact factor: 3.240